A trial looking at zilovertamab vedotin by itself or with nemtabrutinib for B cell lymphoma and B cell leukaemia (waveLINE-006)

This trial is looking at zilovertamab vedotin by itself or in combination with nemtabrutinib for people with B cell lymphomas and B cell leukaemia.

B cell lymphoma and B cell leukaemia are also called B cells cancers.

It is open to people with one of the following B cell cancers that has come back or got worse during treatment:

• mantle cell lymphoma

• follicular lymphoma

• Richter transformation . This is also called Richter’s syndrome.

You pronounce zilovertamab vedotin as zi-lov-er-ta-mab ve-dot-in.

You pronounce nemtabrutinib as nem-tab-rut-i-nib.